Loading...

LINCOLN Lincoln Pharmaceuticals Ltd Other Special Situation Announcement

Lncl

LNCL

Lincoln Pharmaceuticals Ltd

(LINCOLN)

2025 Announcement

Summary

Summary

Transfer Requests Opening

Compliance Certificate

Annual General Meeting

Shareholder Communication

Management Change

AGM Announcement

Financial Results Publication

Secretarial Auditor Appoint...

Management Changes

Management Change

Compliance Certificate

New Facility Updates

Financial Results Published

Annual Compliance Report

Dividend Claims Reminder

Compliance Certificate

Cautionary Letters Issued

Financial Results Update

Compliance Certificate

RTA Name Change

Price Movement Clarification

Financial Results Update

Compliance Certificate

AGM Notification

AGM Announcement

Newspaper Advertisement

Certificate Submission

Compliance Report

Newspaper Advertisement

Conference Call Outcome

Financial Highlights

Equity Shares Transfer to I...

Investor Call Scheduled

Certificate Submission

Compliance Certificate

Newspaper Advertisement

Certificate Submission

Director Appointments

Completion of Independent D...

Resignation of Director

Resignation Announcement

Financial Results Advertise...

Advisory Letter

Response to BSE

Certificate Submission

Non-Compliance Fine Imposed...

Financial Results Advertise...

Certificate Submission

Newspaper Publication

Financial Statements

External Links:

Data:

LINCOLN PHARMACEUTICALS LTD. has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended December 31, 2024, confirming the receipt and processing of securities for dematerialization.

AI Assistant

Lincoln Pharmaceuticals Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.